Frequently Asked Questions:
COVID-19 has caused disruptions in the supply chain of the global osteoporosis market.
North America accounted for the most heightened share in the global Osteoporosis Drugs market.
Increase in the healthcare expenditure.
The Selective Estrogen Inhibitors Modulator (SERM) segment had a major global market share in 2022.
The injectable segment had a major global market share in 2022.